This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 1992 Oct 7;84(19):1458-60.

doi: 10.1093/jnci/84.19.1458.

MDR1 (P-glycoprotein) gene expression--implications for resistance modifier trials

PMID: 1359150
DOI: 10.1093/jnci/84.19.1458

Editorial

MDR1 (P-glycoprotein) gene expression--implications for resistance modifier trials

P R Twentyman. J Natl Cancer Inst. 1992.

. 1992 Oct 7;84(19):1458-60.

doi: 10.1093/jnci/84.19.1458.

Author

PMID: 1359150
DOI: 10.1093/jnci/84.19.1458

No abstract available

PubMed Disclaimer

Comment on

Clinical correlates of MDR1 (P-glycoprotein) gene expression in ovarian and small-cell lung carcinomas.
Holzmayer TA, Hilsenbeck S, Von Hoff DD, Roninson IB. Holzmayer TA, et al. J Natl Cancer Inst. 1992 Oct 7;84(19):1486-91. doi: 10.1093/jnci/84.19.1486. J Natl Cancer Inst. 1992. PMID: 1359152
Effect of P-glycoprotein expression on sensitivity to hormones in MCF-7 human breast cancer cells.
Clarke R, Currier S, Kaplan O, Lovelace E, Boulay V, Gottesman MM, Dickson RB. Clarke R, et al. J Natl Cancer Inst. 1992 Oct 7;84(19):1506-12. doi: 10.1093/jnci/84.19.1506. J Natl Cancer Inst. 1992. PMID: 1359153

Similar articles

Overexpression of the MDR1 gene and P-glycoprotein in human hepatocellular carcinoma.
Huang CC, Wu MC, Xu GW, Li DZ, Cheng H, Tu ZX, Jiang HQ, Gu JR. Huang CC, et al. J Natl Cancer Inst. 1992 Feb 19;84(4):262-4. doi: 10.1093/jnci/84.4.262. J Natl Cancer Inst. 1992. PMID: 1346405 No abstract available.
Clinical correlates of MDR1 (P-glycoprotein) gene expression in ovarian and small-cell lung carcinomas.
Holzmayer TA, Hilsenbeck S, Von Hoff DD, Roninson IB. Holzmayer TA, et al. J Natl Cancer Inst. 1992 Oct 7;84(19):1486-91. doi: 10.1093/jnci/84.19.1486. J Natl Cancer Inst. 1992. PMID: 1359152
P-glycoprotein and multidrug resistance.
Skubitz KM. Skubitz KM. Am J Clin Pathol. 1990 Jan;93(1):156-7. doi: 10.1093/ajcp/93.1.156. Am J Clin Pathol. 1990. PMID: 1967202 No abstract available.
Multidrug resistance (mdr) genes in human cancer.
Nooter K, Herweijer H. Nooter K, et al. Br J Cancer. 1991 May;63(5):663-9. doi: 10.1038/bjc.1991.152. Br J Cancer. 1991. PMID: 1674875 Free PMC article. Review. No abstract available.
Expression of multidrug-resistance (P-glycoprotein) genes in liver cancers: a molecular example of the convergence theory of hepatocarcinogenesis?
Kuo MT. Kuo MT. Mol Carcinog. 1993;7(2):73-5. doi: 10.1002/mc.2940070203. Mol Carcinog. 1993. PMID: 8096140 Review. No abstract available.

See all similar articles

Cited by

MDR1 gene expression in primary colorectal carcinomas.
Pirker R, Wallner J, Gsur A, Götzl M, Zöchbauer S, Scheithauer W, Depisch D. Pirker R, et al. Br J Cancer. 1993 Oct;68(4):691-4. doi: 10.1038/bjc.1993.411. Br J Cancer. 1993. PMID: 8398695 Free PMC article.
Temozolomide reverses doxorubicin resistance by inhibiting P-glycoprotein in malignant glioma cells.
Zhang R, Saito R, Shibahara I, Sugiyama S, Kanamori M, Sonoda Y, Tominaga T. Zhang R, et al. J Neurooncol. 2016 Jan;126(2):235-42. doi: 10.1007/s11060-015-1968-x. Epub 2015 Nov 4. J Neurooncol. 2016. PMID: 26530267
Development of multidrug-resistance convertors: sense or nonsense?
van Zuylen L, Nooter K, Sparreboom A, Verweij J. van Zuylen L, et al. Invest New Drugs. 2000 Aug;18(3):205-20. doi: 10.1023/a:1006487003814. Invest New Drugs. 2000. PMID: 10958589 Review.
Classical multidrug resistance in acute myeloid leukaemia.
Paietta E. Paietta E. Med Oncol. 1997 Mar;14(1):53-60. doi: 10.1007/BF02990947. Med Oncol. 1997. PMID: 9232613 Review.
Interaction of alpha-interferon with chemotherapeutic agents: effects on cytotoxic drug metabolism and multiple drug resistance.
Sewell GJ. Sewell GJ. Med Oncol. 1995 Mar;12(1):9-14. doi: 10.1007/BF01571403. Med Oncol. 1995. PMID: 8542251 Review. No abstract available.

See all "Cited by" articles

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- Silverchair Information Systems
Medical
- ClinicalTrials.gov